Europe Automated Cell Counters Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Automated Cell Counters Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Automated Cell Counters Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Automated Cell Counters Market Regional Analysis

6.2 Europe Automated Cell Counters Market Revenue 2020-2028 (US$ Million)

6.3 Europe Automated Cell Counters Market Forecast Analysis

7. Europe Automated Cell Counters Market Analysis – by Type

7.1 Hemocytometer

7.1.1 Overview
7.1.2 Hemocytometer: Europe Automated Cell Counters Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Flow Cytometers

7.2.1 Overview
7.2.2 Flow Cytometers: Europe Automated Cell Counters Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Electrical Impedance Coulter Counters

7.3.1 Overview
7.3.2 Electrical Impedance Coulter Counters: Europe Automated Cell Counters Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.4 Spectrophotometers

7.4.1 Overview
7.4.2 Spectrophotometers: Europe Automated Cell Counters Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Europe Automated Cell Counters Market Analysis – by End User

8.1 Hospitals

8.1.1 Overview
8.1.2 Hospitals: Europe Automated Cell Counters Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Research Laboratories

8.2.1 Overview
8.2.2 Research Laboratories: Europe Automated Cell Counters Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Diagnostics Centers

8.3.1 Overview
8.3.2 Diagnostics Centers: Europe Automated Cell Counters Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Europe Automated Cell Counters Market – Europe Analysis

9.1 Overview

9.2 Europe

9.2.1 Europe Automated Cell Counters Market Breakdown, by Key Country, 2023 and 2028 (%)
9.2.1.1 Europe Automated Cell Counters Market – Revenue and Forecast Analysis – by Country
9.2.1.1 UK: Europe Automated Cell Counters Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.1.1 UK: Europe Automated Cell Counters Market Breakdown, by Type
9.2.1.1.2 UK: Europe Automated Cell Counters Market Breakdown, by End User

9.2.1.2 Germany: Europe Automated Cell Counters Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.2.1 Germany: Europe Automated Cell Counters Market Breakdown, by Type
9.2.1.2.2 Germany: Europe Automated Cell Counters Market Breakdown, by End User

9.2.1.3 France: Europe Automated Cell Counters Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.3.1 France: Europe Automated Cell Counters Market Breakdown, by Type
9.2.1.3.2 France: Europe Automated Cell Counters Market Breakdown, by End User

9.2.1.4 Russia: Europe Automated Cell Counters Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.4.1 Russia: Europe Automated Cell Counters Market Breakdown, by Type
9.2.1.4.2 Russia: Europe Automated Cell Counters Market Breakdown, by End User

9.2.1.5 Italy: Europe Automated Cell Counters Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.5.1 Italy: Europe Automated Cell Counters Market Breakdown, by Type
9.2.1.5.2 Italy: Europe Automated Cell Counters Market Breakdown, by End User

9.2.1.6 Rest of Europe: Europe Automated Cell Counters Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.6.1 Rest of Europe: Europe Automated Cell Counters Market Breakdown, by Type
9.2.1.6.2 Rest of Europe: Europe Automated Cell Counters Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Eppendorf

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Thermo Fisher Scientific Inc.

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Countstar Inc.

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Bio-Rad Laboratories, Inc.

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 F. Hoffman-La Roche Ltd

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Chemometec A/S

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 ALIGNED GENETICS

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Beckman Coulter, Inc. (Danaher)

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 Nanoentek

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

12.10 Olympus Corporation

12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

12.11 MERCK KGaA

12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments

12.12 Sysmex Corporation

12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments

12.13 Agilent Technologies, Inc.

12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments

12.14 Abbott

12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 Financial Overview
12.14.5 SWOT Analysis
12.14.6 Key Developments

12.15 Nexcelom Bioscience LLC.

12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 Financial Overview
12.15.5 SWOT Analysis
12.15.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

Europe Automated Cell Counters Market

Analysis – by Type (Hemocytometer, Flow Cytometers, Electrical Impedance Coulter Counters, and Spectrophotometers) and End User (Hospitals, Research Laboratories, Diagnostics Centers, and Others)